Chemotherapy

A new proof of concept study has demonstrated how certain types of protective gut bacteria can help negate the damaging side effects of toxic chemotherapy drugs, raising the prospect of future probiotics designed to enhance gut health in cancer patients.

Researchers at Yale University have shown how skin cancer could one day be treated with a simple injection. The team found that they could shrink tumors by injecting them with adhesive nanoparticles loaded with chemotherapy drugs.

A compelling study is suggesting all cancer cells may have the capacity to enter states of dormancy as a survival mechanism to avoid destruction from chemotherapy. And the mechanism these cells deploy notably resembles one used by hibernating animals.

A new study led by researchers from University College London suggests that combining traditional chemotherapy with an experimental therapy that uses magnetic nanoparticles to heat tumor cells could significantly enhance the efficacy of both treatments.

We know radiation therapy for cancer is an aggressively toxic treatment methodology. New research suggests certain gut bacteria species may protect an organism from the harmful effects of radiation, and human trials are planned to test these findings.

The results of a trial investigating fasting as an adjunct to chemotherapy have been published, finding the simple dietary intervention can improve the outcome of cancer chemotherapy and potentially reduce cellular damage associated with the therapy.

A new study has demonstrated the profound influence diet and gut bacteria have on the effectiveness and toxicity of drugs used in chemotherapy. The research concludes the complexity of drug, diet, and bacteria interactions in humans is “astronomical.”

The brain’s own defense mechanism often prevents treatment of brain cancers. But a new experimental treatment has shown success in mice, with carbon nanoparticles able to sneak through the blood-brain barrier and deliver drugs directly to tumors.

Doctors fight cancer with everything from radiation to chemicals to light-reactive particles, with mixed outcomes. Now, a new study has combined two approaches – chemotherapy and light therapy – into one drug, with promising results.

Australian researchers have affirmed an unusual, almost paradoxical, observation that cancer patients with high body mass index tend to display greater survival rates than patients with average healthy weights.

New research, led by scientists from the University of Rochester, has homed in on a mechanism responsible for causing the cognitive impairment seen in patients who receive cranial radiotherapy for brain cancer.

Scientists at the Salk Institute have been researching some of the cellular processes triggered by chemotherapy treatments, uncovering a mechanism that could lead to new and improved treatments that prevent mitochondria hindering their effectiveness.